Business Description
Quantrx Biomedical Corp
NAICS : 339112
SIC : 3841
ISIN : US74765N1090
Description
Quantrx Biomedical Corp operates towards the development and commercialization of patented mini form pad (PAD) based products. The PAD products are based on the company's non-woven disposable absorbent pad technology and it is involved in the PAD-based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its platforms include inSync(R), Unique(TM), and OEM branded over-the-counter and laboratory testing products.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.06 | |||||
| 9-Day RSI | 1.93 | |||||
| 14-Day RSI | 7.89 | |||||
| 6-1 Month Momentum % | -62.5 | |||||
| 12-1 Month Momentum % | -81.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.62 | |||||
| EV-to-EBITDA | -2.62 | |||||
| Earnings Yield (Greenblatt) % | -38.17 | |||||
| FCF Yield % | -300 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:QTXB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quantrx Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.01 | ||
| Beta | 17.76 | ||
| Volatility % | 1417.5 | ||
| 14-Day RSI | 7.89 | ||
| 14-Day ATR ($) | 0.000062 | ||
| 20-Day SMA ($) | 0.00098 | ||
| 12-1 Month Momentum % | -81.01 | ||
| 52-Week Range ($) | 0.00001 - 0.0079 | ||
| Shares Outstanding (Mil) | 78.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quantrx Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quantrx Biomedical Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quantrx Biomedical Corp Frequently Asked Questions
What is Quantrx Biomedical Corp(QTXB)'s stock price today?
The current price of QTXB is $0.00. The 52 week high of QTXB is $0.01 and 52 week low is $0.00.
When is next earnings date of Quantrx Biomedical Corp(QTXB)?
The next earnings date of Quantrx Biomedical Corp(QTXB) is .
Does Quantrx Biomedical Corp(QTXB) pay dividends? If so, how much?
Quantrx Biomedical Corp(QTXB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers